The luciferase assay market is poised to embark on an impressive growth trajectory, with a promising CAGR of 7.00%. Distinguished industry experts have forecasted that by the year 2034, the market is anticipated to soar to an astounding valuation of USD 3,022.90 million, depicting a substantial upsurge from its present value of USD 1,536.70 million
| Attributes | Details |
|---|---|
| Luciferase Assay Market Size, 2024 | USD 1,536.70 million |
| Market Size, 2034 | USD 3,022.90 million |
| Value CAGR (2024 to 2034) | 7.00% |
| Drivers |
|
|---|---|
| Challenges |
|
| Attributes | Details |
|---|---|
| Product Type | Luciferase Assays |
| Market share in 2024 | 35.00% |
Luciferase assays are gaining popularity among researchers due to their compatibility with a wide range of products such as reagents, kits, and instruments. Moreover, the upsurge in drug discovery and development has led to the increasing adoption of these assays in recent years.
Furthermore, the increasing availability of advanced technologies, such as high-throughput screening systems and automated instrumentation, has made it easier to perform these assays on a large scale.
| Attributes | Details |
|---|---|
| Application | Protein-protein Interaction |
| Market Share in 2024 | 27.60% |
Rising need for understanding complex cellular processes and developing effective drugs to treat specific diseases has led researchers to use protein-protein interactions as a common method. Increasing focus on personalized medicine is driving the growth of the protein-protein interaction segment.
Personalized medicine involves developing drugs tailored to the genetic makeup of individual patients. To do this, researchers need to study the interactions between specific proteins involved in disease pathways.
| Countries | CAGR from 2024 to 2034 |
|---|---|
| United States | 3.20% |
| China | 6.00% |
| Germany | 2.50% |
| India | 7.60% |
| Australia | 5.30% |
The CAGR of the market in the United States during the forecast period is anticipated to be 3.20%. The United States dominates the market in North America due to strong government financing for research into innovative test methodologies. Although demand for luciferase assays in this country has remained robust, operations targeting the market have recently shifted.
The market is expected to register a CAGR of 6.00% in China through 2034. The government plays a major role in the growth of the luciferase assay market in China by providing funding and facilities for drug discoveries and development.
China has greater development potential in this industry. Many firms are focusing their resources on economically growing regions, especially in the Asia Pacific, to explore product potential that is expected to increase luciferase assay sales.
The market is expected to progress at a CAGR of 2.50% in Germany throughout the forecast period. The need for advanced technology is anticipated to drive the luciferase assay market in Germany.
By providing high sensitivity, low background, and real-time detection capabilities, these assays are gaining more market potential than traditional methods in the country. Moreover, the high usage of luciferase assays in laboratories across Germany, especially for pharmaceutical purposes, has been observed in recent years.
The market is expected to progress at a CAGR of 5.30% in Australia throughout the forecast period. Escalating demand for biotechnology and life science research is driving up the demand for the luciferase assay market in the region. Moreover, the expanding pharmaceutical industry is anticipated to gain a major market share in Australia in the coming years.
The market is expected to progress at a CAGR of 7.60% in India. Advancements in technology have led to the development of new and improved luciferase assay kits, making them more accessible and affordable to researchers and scientists in India.
Moreover, the luciferase assay market in India is expected to grow due to the increasing demand for personalized medicine in the region. As personalized medicine becomes more prevalent, there will be a need for more precise and efficient tools to diagnose and treat diseases.
The luciferase assay market is highly competitive, with numerous players involved in the development and production of assay kits and reagents. Companies are constantly innovating and launching new products to stay ahead of the competition.
Additionally, partnerships, collaborations, and mergers and acquisitions are common strategies these players adopt to expand their market presence and enhance their product portfolio.
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a leading biotechnology company that offers a wide range of products and services to the life science, healthcare, and industrial markets. The company has a global presence and operates through four business segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
One of the key products offered by Thermo Fisher Scientific Inc. is its range of Luciferase Assays. These assays are designed to measure the activity of luciferase enzymes, which are commonly used as reporter genes in molecular biology research.
The assay kits offered by Thermo Fisher Scientific Inc. are used to measure the expression of genes, monitor protein-protein interactions, and detect changes in cellular signaling pathways.
PerkinElmer Inc.
PerkinElmer Inc. is a global leader in providing innovative products, services, and solutions to the life sciences, diagnostics, and applied markets. The company's diverse portfolio includes a wide range of products, including analytical instruments, reagents, software, and consumables.
PerkinElmer's luciferase assays are among its most popular products, offering researchers a range of options for measuring gene expression and monitoring cellular signaling pathways.
PerkinElmer's assays are designed to be highly sensitive, reliable, and easy to use. The company offers a range of assay formats, including reporter gene assays, dual-luciferase reporter assays, and firefly assay kits.
Acquisition, Mergers, and Recent Development
| Attribute | Details |
|---|---|
| Estimated Market Size (2024) | USD 1,536.70 million |
| Projected Market Size (2034) | USD 3,022.90 million |
| Anticipated Growth Rate (2024 to 2034) | 7.00% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | USD million or billion for Value and Units for Volume |
| Key Regions Covered | North America; Latin America; Europe; Middle East & Africa (MEA); East Asia; South Asia and Oceania |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, Spain, Italy, France, United Kingdom, Russia, China, India, Australia & New Zealand, GCC Countries, and South Africa |
| Key Segments Covered | Product Type and Application |
| Key Companies Profiled | Promega Corporation; PerkinElmer Inc.; Thermo Fisher Scientific Inc.; Abcam plc; Geno Technology Inc.; BioTek Instruments, Inc.; Becton, Dickinson and Company; Merck KGaA; Cell Signaling Technology, Inc.; Danaher Corporation. |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034
Table 2: Global Market Value (US$ Million) Forecast by Assay Type, 2019 to 2034
Table 3: Global Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 4: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 5: North America Market Value (US$ Million) Forecast by Assay Type, 2019 to 2034
Table 6: North America Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 8: Latin America Market Value (US$ Million) Forecast by Assay Type, 2019 to 2034
Table 9: Latin America Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 10: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 11: Western Europe Market Value (US$ Million) Forecast by Assay Type, 2019 to 2034
Table 12: Western Europe Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 13: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 14: Eastern Europe Market Value (US$ Million) Forecast by Assay Type, 2019 to 2034
Table 15: Eastern Europe Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 16: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 17: South Asia and Pacific Market Value (US$ Million) Forecast by Assay Type, 2019 to 2034
Table 18: South Asia and Pacific Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 19: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 20: East Asia Market Value (US$ Million) Forecast by Assay Type, 2019 to 2034
Table 21: East Asia Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Assay Type, 2019 to 2034
Table 24: Middle East and Africa Market Value (US$ Million) Forecast by Application, 2019 to 2034
Figure 1: Global Market Value (US$ Million) by Assay Type, 2024 to 2034
Figure 2: Global Market Value (US$ Million) by Application, 2024 to 2034
Figure 3: Global Market Value (US$ Million) by Region, 2024 to 2034
Figure 4: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034
Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 7: Global Market Value (US$ Million) Analysis by Assay Type, 2019 to 2034
Figure 8: Global Market Value Share (%) and BPS Analysis by Assay Type, 2024 to 2034
Figure 9: Global Market Y-o-Y Growth (%) Projections by Assay Type, 2024 to 2034
Figure 10: Global Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 11: Global Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 12: Global Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 13: Global Market Attractiveness by Assay Type, 2024 to 2034
Figure 14: Global Market Attractiveness by Application, 2024 to 2034
Figure 15: Global Market Attractiveness by Region, 2024 to 2034
Figure 16: North America Market Value (US$ Million) by Assay Type, 2024 to 2034
Figure 17: North America Market Value (US$ Million) by Application, 2024 to 2034
Figure 18: North America Market Value (US$ Million) by Country, 2024 to 2034
Figure 19: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 22: North America Market Value (US$ Million) Analysis by Assay Type, 2019 to 2034
Figure 23: North America Market Value Share (%) and BPS Analysis by Assay Type, 2024 to 2034
Figure 24: North America Market Y-o-Y Growth (%) Projections by Assay Type, 2024 to 2034
Figure 25: North America Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 26: North America Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 27: North America Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 28: North America Market Attractiveness by Assay Type, 2024 to 2034
Figure 29: North America Market Attractiveness by Application, 2024 to 2034
Figure 30: North America Market Attractiveness by Country, 2024 to 2034
Figure 31: Latin America Market Value (US$ Million) by Assay Type, 2024 to 2034
Figure 32: Latin America Market Value (US$ Million) by Application, 2024 to 2034
Figure 33: Latin America Market Value (US$ Million) by Country, 2024 to 2034
Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 37: Latin America Market Value (US$ Million) Analysis by Assay Type, 2019 to 2034
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Assay Type, 2024 to 2034
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Assay Type, 2024 to 2034
Figure 40: Latin America Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 41: Latin America Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 43: Latin America Market Attractiveness by Assay Type, 2024 to 2034
Figure 44: Latin America Market Attractiveness by Application, 2024 to 2034
Figure 45: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 46: Western Europe Market Value (US$ Million) by Assay Type, 2024 to 2034
Figure 47: Western Europe Market Value (US$ Million) by Application, 2024 to 2034
Figure 48: Western Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 49: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 50: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 51: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 52: Western Europe Market Value (US$ Million) Analysis by Assay Type, 2019 to 2034
Figure 53: Western Europe Market Value Share (%) and BPS Analysis by Assay Type, 2024 to 2034
Figure 54: Western Europe Market Y-o-Y Growth (%) Projections by Assay Type, 2024 to 2034
Figure 55: Western Europe Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 56: Western Europe Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 57: Western Europe Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 58: Western Europe Market Attractiveness by Assay Type, 2024 to 2034
Figure 59: Western Europe Market Attractiveness by Application, 2024 to 2034
Figure 60: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 61: Eastern Europe Market Value (US$ Million) by Assay Type, 2024 to 2034
Figure 62: Eastern Europe Market Value (US$ Million) by Application, 2024 to 2034
Figure 63: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 64: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 65: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 66: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 67: Eastern Europe Market Value (US$ Million) Analysis by Assay Type, 2019 to 2034
Figure 68: Eastern Europe Market Value Share (%) and BPS Analysis by Assay Type, 2024 to 2034
Figure 69: Eastern Europe Market Y-o-Y Growth (%) Projections by Assay Type, 2024 to 2034
Figure 70: Eastern Europe Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 71: Eastern Europe Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 72: Eastern Europe Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 73: Eastern Europe Market Attractiveness by Assay Type, 2024 to 2034
Figure 74: Eastern Europe Market Attractiveness by Application, 2024 to 2034
Figure 75: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 76: South Asia and Pacific Market Value (US$ Million) by Assay Type, 2024 to 2034
Figure 77: South Asia and Pacific Market Value (US$ Million) by Application, 2024 to 2034
Figure 78: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034
Figure 79: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 80: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 81: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 82: South Asia and Pacific Market Value (US$ Million) Analysis by Assay Type, 2019 to 2034
Figure 83: South Asia and Pacific Market Value Share (%) and BPS Analysis by Assay Type, 2024 to 2034
Figure 84: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Assay Type, 2024 to 2034
Figure 85: South Asia and Pacific Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 86: South Asia and Pacific Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 87: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 88: South Asia and Pacific Market Attractiveness by Assay Type, 2024 to 2034
Figure 89: South Asia and Pacific Market Attractiveness by Application, 2024 to 2034
Figure 90: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 91: East Asia Market Value (US$ Million) by Assay Type, 2024 to 2034
Figure 92: East Asia Market Value (US$ Million) by Application, 2024 to 2034
Figure 93: East Asia Market Value (US$ Million) by Country, 2024 to 2034
Figure 94: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 95: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 96: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 97: East Asia Market Value (US$ Million) Analysis by Assay Type, 2019 to 2034
Figure 98: East Asia Market Value Share (%) and BPS Analysis by Assay Type, 2024 to 2034
Figure 99: East Asia Market Y-o-Y Growth (%) Projections by Assay Type, 2024 to 2034
Figure 100: East Asia Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 101: East Asia Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 102: East Asia Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 103: East Asia Market Attractiveness by Assay Type, 2024 to 2034
Figure 104: East Asia Market Attractiveness by Application, 2024 to 2034
Figure 105: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 106: Middle East and Africa Market Value (US$ Million) by Assay Type, 2024 to 2034
Figure 107: Middle East and Africa Market Value (US$ Million) by Application, 2024 to 2034
Figure 108: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034
Figure 109: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 110: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 111: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 112: Middle East and Africa Market Value (US$ Million) Analysis by Assay Type, 2019 to 2034
Figure 113: Middle East and Africa Market Value Share (%) and BPS Analysis by Assay Type, 2024 to 2034
Figure 114: Middle East and Africa Market Y-o-Y Growth (%) Projections by Assay Type, 2024 to 2034
Figure 115: Middle East and Africa Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 116: Middle East and Africa Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 117: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 118: Middle East and Africa Market Attractiveness by Assay Type, 2024 to 2034
Figure 119: Middle East and Africa Market Attractiveness by Application, 2024 to 2034
Figure 120: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
The CAGR of the market in the United States from 2024 to 2034 is estimated to be 3.20%.
The market is expected to grow at a CAGR of 7.00%.
The market size is expected to be worth USD 1,536.70 million in 2024.
The CAGR of the market in China from 2024 to 2034 is estimated to be 6.00%.
The market is estimated to get as big as USD 3,022.90 million by 2034.
The market can be divided into the following segments: product type, application, and region.
Explore Similar Insights
Luciferase Assay Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
